Comparison of diagnostic sensitivity of [ 18 F]fluoroestradiol and [ 18 F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer

ConclusionsThe restaging of patients who had ER-positive primary breast cancer and present with recurrent disease may include [18F]FES PET/CT as an initial test when standard imaging studies are equivocal or suspicious.
Source: EJNMMI Research - Category: Radiology Source Type: research